Exotoxin A of Pseudomonas aeruginosa asserts its cellular toxicity through ADP-ribosylation of translation elongation factor 2, predicated on binding to speci®c cell surface receptors and intracellular traf®cking via a complex pathway that ultimately results in translocation of an enzymatic activity into the cytoplasm. In early work, the crystallographic structure of exotoxin A was determined to 3.0 A Ê resolution, revealing a tertiary fold having three distinct structural domains; subsequent work has shown that the domains are individually responsible for the receptor binding (domain I), transmembrane targeting (domain II), and ADP-ribosyl transferase (domain III) activities, respectively. Here, we report the structures of wild-type and W281A mutant toxin proteins at pH 8.0, re®ned with data to 1.62 A Ê and 1.45 A Ê resolution, respectively. The re®ned models clarify several ionic interactions within structural domains I and II that may modulate an obligatory conformational change that is induced by low pH. Proteolytic cleavage by furin is also obligatory for toxicity; the W281A mutant protein is substantially more susceptible to cleavage than the wild-type toxin. The tertiary structures of the furin cleavage sites of the wild-type and W281 mutant toxins are similar; however, the mutant toxin has signi®cantly higher B-factors around the cleavage site, suggesting that the greater susceptibility to furin cleavage is due to increased local disorder/¯exibility at the site, rather than to differences in static tertiary structure. Comparison of the re®ned structures of fulllength toxin, which lacks ADP-ribosyl transferase activity, to that of the enzymatic domain alone reveals a salt bridge between Arg467 of the catalytic domain and Glu348 of domain II that restrains the substrate binding cleft in a conformation that precludes NAD binding. The re®ned structures of exotoxin A provide precise models for the design and interpretation of further studies of the mechanism of intoxication.
Exotoxin A of Pseudomonas aeruginosa asserts its cellular toxicity through ADP-ribosylation of translation elongation factor 2, predicated on binding to speci®c cell surface receptors and intracellular traf®cking via a complex pathway that ultimately results in translocation of an enzymatic activity into the cytoplasm. In early work, the crystallographic structure of exotoxin A was determined to 3.0 A Ê resolution, revealing a tertiary fold having three distinct structural domains; subsequent work has shown that the domains are individually responsible for the receptor binding (domain I), transmembrane targeting (domain II), and ADP-ribosyl transferase (domain III) activities, respectively. Here, we report the structures of wild-type and W281A mutant toxin proteins at pH 8.0, re®ned with data to 1.62 A Ê and 1.45 A Ê resolution, respectively. The re®ned models clarify several ionic interactions within structural domains I and II that may modulate an obligatory conformational change that is induced by low pH. Proteolytic cleavage by furin is also obligatory for toxicity; the W281A mutant protein is substantially more susceptible to cleavage than the wild-type toxin. The tertiary structures of the furin cleavage sites of the wild-type and W281 mutant toxins are similar; however, the mutant toxin has signi®cantly higher B-factors around the cleavage site, suggesting that the greater susceptibility to furin cleavage is due to increased local disorder/¯exibility at the site, rather than to differences in static tertiary structure. Comparison of the re®ned structures of fulllength toxin, which lacks ADP-ribosyl transferase activity, to that of the enzymatic domain alone reveals a salt bridge between Arg467 of the catalytic domain and Glu348 of domain II that restrains the substrate binding cleft in a conformation that precludes NAD binding. The re®ned structures of exotoxin A provide precise models for the design and interpretation of further studies of the mechanism of intoxication.
Introduction
Exotoxin A of Pseudomonas aeruginosa (PE) 1 is a virulence factor secreted in response to environmental iron scarcity. 2 The mature protein has 613 amino acid residues and four disul®de linkages. PE is highly toxic to eukaryotic cells, causing the arrest of protein synthesis. This is accomplished through enzymatic ADP-ribosylation of a speci®c post-translationally modi®ed histidine of eEF-2 (diphthamide). 3 ± 5 At a minimum, presentation of the enzymatic activity of PE in the cytoplasm of target cells requires: (i) cell surface receptor binding and internalization; (ii) proteolytic hydrolysis between Arg279 and Gly280; (iii) reduction of the Cys265-Cys287 disul®de; and (iv) transmembrane translocation of the catalytic domain into the cytoplasmic compartment. Contemporary models for the pathway of intoxication envisage that PE ®rst binds the a 2 -macroglobulin receptor and is internalized into endosomes. 6 Then, the toxin is cleaved by the protease furin. 7, 8 In vitro, furin cleavage occurs only at low pH (typically 5.5 in published assays). 7, 9 In vivo the cleavage is relatively inef®-cient, and is believed to occur in endosomes, where the low pH environment induces a conformational change that makes the toxin furin-susceptible. 9, 10 Once cut, the toxin is shuttled to the endoplasmic reticulum (ER) and, predicated on the carboxy-terminal lysine having been removed (possibly by a plasma variant of carboxypeptidase early in the intoxication process 11 ), is retained there by the carboxy-terminal REDL sequence, which mimics a ER retention signal and binds the KDEL receptor. 12 Subsequently, the furin-generated 37 kDa carboxy-terminal fragment of PE, which includes the enzymatic domain, is translocated into the cytoplasm. The 37 kDa fragment may masquerade as an unfolded/misfolded protein that is exported from the ER through the retrograde protein translocation system; 13, 14 an obligatory step in this process is partial unfolding of the furin-nicked PE molecule and reduction of the Cys265-Cys287 disul®de by cellular factors. 15 In the cytoplasm, the enzymatic domain circumvents degradation by the proteasome long enough to enzymatically ADP-ribosylate eEF-2, thereby inhibiting protein synthesis.
The crystallographic structure of native wildtype PE was determined to 3.0 A Ê resolution several years ago, 16 before ef®cient methodologies for high-resolution X-ray data collection and protein model re®nement were available. Although the model was relatively imprecise by contemporary standards, it revealed the overall tertiary structure of the molecule, which consists of three domains. Domain I (residues 1-252, called Ia; and 365-404, called Ib) has a core formed of a 13-stranded b-roll; domain II (residues 253-364) is a bundle of six a-helices; and domain III (residues 405-613), the enzymatic domain, has a complex a/b-folding topology, distinct from classical nucleotide binding motifs. It was suggested, based on the modular domain structure of the toxin, that domain I was responsible for receptor binding, domain II was required for transmembrane targeting (although the mechanism by which this occurs remains unclear), and domain III was the ADP-ribosyl transferase; these hypotheses have been con®rmed by subsequent experiments. 17, 18 Knowledge of the tripartite domain structure of PE has been exploited extensively in the construction of chimeric toxins that target speci®c cell types through replacement of domain Ia with a cytokine or a monoclonal antibody fragment. 19 Structures of several other bacterial ADP-ribosylating exotoxins have been solved in recent years. The structure of the isolated enzymatic domain III of PA has been solved to 2.3 A Ê resolution, revealing a conformational change in a¯exible loop of the substrate binding cleft which allows substrates to bind in a catalytically productive manner when the domain is untethered from the rest of the molecule. 20, 21 Diphtheria toxin (DT) has a threedomain organization, reminiscent of PE, although the catalytic domain is amino-terminal rather than carboxy-terminal. 22 DT ADP-ribosylates eEF-2, with a target speci®city identical to that of PE. The heat-labile toxin (LT) from Escherichia coli, a close homolog of cholera toxin, has an AB 5 quaternary structure, 23 where the pentameric B subunits bind gangliosides, and the A subunit is the enzymatic domain. Its intracellular target is the Gs a protein, which stimulates adenylate cyclase. Similarly, the pertussis toxin (PT) is composed of an enzymatic domain and a pentameric receptor binding oligomer constructed from four heteroprotomers (with two copies of one protomer and one copy of each of the other three). 24 The catalytic domain of PT ADP-ribosylates Gi a , an inhibitor of adenylate cyclase, as well as transducin. Despite negligible sequence similarity between members of this group of toxins, their catalytic ADP-ribosyl transferase domains have a similar tertiary fold. 23, 24 This``ADP-ribosyl transferase'' fold has been found in the enzymatic VP2 domain of a Bacillus cereus insecticidal toxin, 25 as well as in the core of vertebrate poly(ADP ribose) polymerase. 26 Hence domain III of PE appears to be a topologically unique fold that is conserved for the speci®c activity of transferring the ADP-ribosyl moiety of NAD to a spectrum of cellular targets. Although the structures of the catalytic domains of these toxins are similar, the proteins are more diverse in the routes they employ to gain access to the cytoplasm and the mechanisms by which they activate their enzymatic domains. The enzymatic domain of DT is thought to translocate directly from the endosome into the cytoplasm. 27, 28 In contrast, PT, 29 LT and cholera toxin, 30 and PE 12, 31 are distinguished by the utilization of a more circuitous route through the ER and the protein retrograde transport system. Despite success in elucidating the pathway by which the catalytic activity of PE reaches the cell cytoplasm, as well as advances in utilizing chimeric toxins as therapeutic agents, questions still remain regarding the molecular mechanisms of several steps in the PE intoxication scheme, including receptor binding, pH-dependent activation, and transmembrane targeting. Accurate molecular models of wild-type PE and mutants with altered function will facilitate the design and interpretation of experiments delineating the mechanisms of these activities at the molecular level. In this context, we have established conditions that allow high-resolution data collection on PE crystals, and have collected data and re®ned the structures of wild-type PE (natural toxin produced by P. aeruginosa 32 ) and a W281A mutant with enhanced susceptibility to furin cleavage but decreased cellular toxicity (recombinant protein from E. coli 33 ) to 1.62 A Ê and 1.45 A Ê resolution, respectively. The PE proteins in this crystal form (and by implication, the molecular models) represent the extracellular state of the toxin, before it has undergone endocytosis and proteolytic processing. As such, the PE structures represent`s napshots'' of the protein before it progresses through a series of complex biochemical activities that ultimately culminate in cellular intoxication. Here, we present the structures and discuss their relationship to the activities of the toxin.
Results and Discussion
Quality and comparison of the refined models Both the wild-type and W281A mutant PE models are well de®ned, with average B values of 29.5 A Ê 2 and 21.9 A Ê 2 , respectively. Crystals of the mutant protein yielded data to somewhat higher resolution due to lower overall mosaicity (0.18
for wild-type), which can probably be ascribed to improvement in the method of cryoprotection, rather than any intrinsic difference in the two proteins. Several segments of polypeptide on the surfaces of the molecules are poorly ordered, and in the ®nal stages of re®nement, interpretation was aided by cross-checking the conformations between the two structures and using the betterordered representative as a guide for the more poorly ordered. In the end, two segments of polypeptide could not be interpreted: residues 179-184 in domain I, and residues 607-613 at the carboxy terminus. Residues 488-491 are the most poorly ordered segment of polypeptide in the wild-type structure, with B-factors in the range 75-88 A Ê 2 ; the model of this segment reveals little more than the average path of the polypeptide backbone in this region.
The average coordinate error estimated from a cross-validated Luzzati plot 34, 35 is 0.20 A Ê for the wild-type structure, 0.18 A Ê for the mutant. A further indication of the model quality can be seen in representative 2F o À F c and anomalous difference Fourier maps, which reveal monovalent ion binding sites in the crystals (Figure 1 ). The best-occupied site occurs between the surface guanidinium groups of Arg154 and Arg505 H ( Figure 1(a) ; the prime designates a symmetryrelated molecule) at a crystal lattice interface.
A less distinct solvent peak near the aminoterminal end of an a-helix in domain III has been assigned as a second Cl ion as well, due to its anomalous signal. This ion does not appear to serve any structural function, but may coordinate due to the solvent accessibility of the backbone amides at residues Asp589 and Lys590 where the ion is afforded a favorable helix dipole interaction. A sodium ion is observed to mediate a second lattice packing contact between the crystallographically related carbonyl oxygen atoms of Asn62 and Pro598
H (Figure 1(b) ). Although this atom has no detectable anomalous signal{, its pentacoordinate geometry and close ligand distances of 2.4 A Ê 36 are consistent with Na . The protein carbonyl oxygen atoms contribute axial and equatorial ligands of a trigonal bipyramid, similar to that seen in the Na structure of dialkylglycine decarboxylase, 37 with H 2 O molecules contributing the other ligands. High ionic strength (>1.0 M NaCl) is required for crystallization of PE. The interactions of monovalent ions with the toxin that we observe in the presence of 1.0 M NaCl are probably due to lowaf®nity binding sites and are unlikely to be signi®-cant for toxin activity under in vivo conditions.
The average rms displacement between the C a atoms of the re®ned wild-type model versus those of the model reported by Allured et al. 16 is 0.58 A Ê , con®rming the original polypeptide trace. The average rms difference in backbone atomic positions between wild-type and the W281A mutant structures is 0.60 A Ê . When backbone atoms of individual domains are superimposed, the average rms differences are 0.28 A Ê , 0.32 A Ê and 0.84 A Ê for domains I, II and III, respectively; when polypeptide segments that differ substantially in conformation are omitted in domain III, the value is reduced from 0.84 A Ê to 0.37 A Ê .
The interface between domains suggests residues that may control the low pH-induced conformational change
The three-domain architecture of PE is illustrated in Figure 2 . The last six carboxy-terminal residues cannot be modeled, due to disorder; they presumably distend from domain III so that the penultimate REDL residues are accessible to the KDEL receptor in the endoplasmic reticulum. The furin cleavage site (between Arg279 and Gly280; highlighted with an arrow in Figure 2 (c)) is in a surface loop between helices of domain II. However, despite its apparent surface presentation in the PE structure, the site is not accessible to furin at neutral pH; a low pH-induced conformational change is required to allow this peptide segment to become protease-susceptible. 7 In vitro biophysical studies have demonstrated a conformational transition in PE in the pH range 3.7-5.4; 38 the molecular details of this transition, whether it is a localized perturbation of the furin cleavage site, or a more global``dissociation'' of domain II from domain I, have not been deter-mined. The re®ned structures of PE reliably delineate speci®c interactions which might play a role in triggering the pH-induced conformational transition (Figure 2(d) and Table 1 ). In the polypeptide segment preceding the furin cleavage site, we see salt bridges between residues of domain II and counterparts in domain Ia, speci®cally His275-Glu80, Arg274-Asp139 (bridged by an interstitial H 2 O molecule), as well as Glu270-Lys114. It is notable that the side-chains of the latter pair of 61 residues are almost completely solvent-inaccessible (Table 1) ; protonation of Glu270 would leave the (presumably) positively charged amino group of the lysine side-chain buried in the protein interior. Somewhat more remote from the furin site is a cluster of interactions between Glu391 of domain Ib and both His262 and Gln263 of domain II; in this cluster, the side-chain of Glu391 is also solvent-inaccessible. One can imagine plausible scenarios in which lowering the pH to $5 would alter the protonation state of one partner in some or all of these salt bridges between domain II and domain I, resulting in, at a minimum, aǹ`u ntethering'' of the furin-susceptible segment of polypeptide from the surface of the molecule, and possibly in a more global disruption of the domain I -domain II interface.
An additional contribution to a pH-dependent conformational change may arise from the destabilization of the interface between domain Ia and Ib at their juncture with domain II. Studies have identi®ed His246, Arg247 and His249 as amino acid residues whose collective mutagenesis to glutamic acid or glycine reduces toxicity on 3T3 cells, whereas mutagenesis of all three residues to lysine, which would retain a positive charge for each of them, does not impair toxicity. 39 These residues, along with Thr89, participate in a cluster of salt bridges and hydrogen bonds with three aspartic acid residues in domain Ib, speci®cally Asp366, Asp384, and Asp387. (Although His246 does not have a direct ion-pairing partner, its imidazole moiety is 5.7 A Ê from the carboxyl group of Glu270, and may contribute to perturbing the local electrostatic environment of the carboxyl group of this residue, which forms a salt bridge with Lys114.) Participation of these residues in the intoxication process argues in favor of a global conformational change preceding furin cleavage, rather than only a localized change around the protease target site, in view of their remoteness from the cleavage site.
In order to asses whether particular residues can be predicted to dominate the low pH-induced destabilization of the structure, we have computed the theoretical change in reaction ®eld energy that would result from protonation of the carboxyl groups of individual aspartic and glutamic residues, using the ®nite difference Poisson-Boltzman method as described in Materials and Methods. Representative results for the wild-type structure are shown in Figure 3 ; similar results were obtained with parallel calculations using the coordinates of the mutant protein. The results shown in Figure 3 are notable for their lack of clear outliers from the general trend; there is no single residue at the interface between domains I and II which, when protonated, induces an unusually large change in calculated reaction ®eld energy for the structure. (Of parenthetical interest, it is notable that the cluster of glutamic acid residues near to and including the catalytically essential Glu553
show the largest positive predicted change in reaction ®eld energy when protonated.) Similar calculations in which the imidazole groups of individual histidine residues were protonated did not reveal any residues with unusually large positive energy changes (data not shown). Many of the positively charged groups which are solvent-inaccessible in the structure, such as the amino group of Lys114, are in relatively polar (albeit buried) environments, which may serve to stabilize the charge if the counterion of the ion pair is neutralized.
In summary, although there are several sets of ionic interaction which, when disrupted by protonation of one moiety, might contribute to the destabilization of the PA toxin structure, computational analysis suggests that no speci®c interaction dominates the process; destabilization may be dependent on multiple contributions from the concerted disruption of a network of ionic interactions. Further computational analysis of this process is underway (T.R. & P.K., unpublished results).
The furin cleavage site
In order to function as a sequence-speci®c endoprotease, furin must recognize an extended unstructured substrate. The consensus sequence for substrate recognition spans at least four residues amino-terminal to the scissile bond, and is given by the consensus sequence R P4 -X P3 -(R/K) P2 -R P1 -(scissile bond)-X P1 H , where arginine is essential at P1, and at least two of three amino acid residues at P2, P4, or P6 must be basic. Furthermore, the P1 H position should be neither hydrophobic nor aliphatic. 40 The furin cleavage site of PE protrudes from the surface of domain II and is well ordered due to forti®cation with numerous main-chain and sidechain hydrogen bond interactions, as well as the Cys265-Cys287 disul®de (Figure 4(a) ). Trp281 lies close to the cleavage site in the P2 H position; one face of the indole ring packs snugly against the side-chains of Leu267 and Thr271 of the helix preceeding the furin loop and Leu284 of the helix following the loop; the other face is completely solvent-exposed (Figure 4) . The structure of the site in the W281A mutant shows no major differences from wild-type; the rms difference in coordinates of the polypeptide backbone between mutant and wild-type from residue 266 to 286 is 0.38 A Ê . However, there is a notable difference in the re®ned B-factors between the mutant and wildtype models; comparison of average main-chain B-factors (where restriction to main-chain atoms circumvents artifactual discrepancies due to sidechain disorder) reveals that the region where the mutant B-factors exceed those of wild-type by the largest positive value (which is to say, the region of greatest static disorder in the mutant relative to wild-type) is precisely at the cleavage site, with a value of $16 A Ê 2 at Arg279 ( Figure 5 ). This is in contrast to the general trend in differences between the two structures, where the average main-chain difference (mutant minus wild-type) is À5.0 A Ê 2 , and most of the larger differences are found in segments of polypeptide on the surface of the molecule that are more poorly ordered in the wildtype model than in the mutant.
Although this information is derived from neutral-pH structures of PE, and cannot be rigorously extrapolated to pH 5, where the molecule is sus- ceptible to furin cleavage, it suggests that the W281A mutation may enhance the susceptibility of PE to furin through greater¯exibility of the cleavage site, rather than through structural distortion. Information on the furin cleavage sites of other toxins is consistent with this suggestion. The robustness of the protease target site in the PE structure is in contrast to those of diphtheria toxin, 22 E. coli heat-labile toxin 41 and the anthrax protective antigen, 42 whose cleavage sites are disordered in the crystals, presumably due to¯exibility. Systematic mutagenesis of the sequence of the cleavage site in PE toward that of diphtheria toxin revealed that replacement of residues 273-282 with their counterpart amino acids from diphtheria toxin (Figure 4(b) ) resulted in essentially 100 % cleavage by furin at pH 5.5, in contrast to the 50 % observed with the wild-type sequence. 33 This replacement introduced glycine residues at positions 274 and 282, and replaced the tryptophan residue at 281 with valine; arguably, these changes would be anticipated to make the cleavage site more¯exible. Along with these data, the structural comparison of the W281A mutant PE structure with wild-type favor the suggestion that¯exibility of the furin cleavage site is an obligatory feature for ef®cient cleavage.
Ironically, although the W281A mutation makes the site substantially more susceptible to furin cleavage, 43 it reduces toxicity of the PE molecule. Additionally, mutation of Leu284 or Tyr289, as well as Trp281, substantially reduces toxicity of PE, despite (in some cases) enhancing susceptibility to furin cleavage. 43 Conservation of these speci®c residues near the cleavage site is apparently mandated by another step in the intoxication process, possibly interaction with an as yet unidenti®ed intracellular component required for toxicity.
The enzymatic domain: activation and activity
Prior to activation, PE is devoid of ADP ribosyl transferase and NAD -glycohydrolase activities and does not bind NAD . The re®ned structures of PE in its proenzyme form helps to clarify the molecular constraints that impair catalytic activity. Independent structures of the enzymatically active domain III alone have been solved with ligands (i) b-methylene-thiazole-4-carboxyamide adenine dinucleotide, an NAD analog (PDB accession code 1AER), giving a structure that mimics the substrate-bound state, 21 and (ii) AMP plus nicotinamide (PDB accession code 1DMA), giving a structure that mimics the product-bound state. 20 When compared to the earlier model of PE (in Table 1 ). An arrowhead indicates the site of furin cleavage. The orientation and color scheme are similar to that of (a).
which two segments of polypeptide, designated L3 and L4 below, were absent from domain III 16 ), these structures revealed that there are no global conformational differences between the active and proenzyme forms of the enzymatic domain. At the same time, they revealed a localized difference in à`¯e xible loop'' that traverses the catalytic cleft, residues 458-463.
The re®ned model of PE elaborates the differences described earlier and also reveals others that were not clearly de®ned by comparisons to the earlier PE structure (Figure 6(a) ). The``¯exible loop'' (L1; average rms displacement 4.1 A Ê ) appears to be the primary determinant of inhibition; it is in aǹ`o pen'' conformation in the enzymatically active domain III structures, while in full-length PE, it is`c losed'' in a manner that sterically blocks NAD binding. Ala457 and Ala464 act as swivel points for the loop. In PE, the well-ordered, closed conformation of L3 is stabilized by a helix from domain II, and most notably, by the side-chain of Arg467, which runs under the loop and forms a salt bridge with Glu348 of domain II. NAD cannot bind until this interaction is disrupted; in PE, the backbone of residues 458-462 and side-chains of Arg458, Gln460 and Leu462 sterically block access of the ribose of the adenosine moiety and the diphosphate to the active site cleft.
Two other loops at the periphery of the substrate binding cleft show alternative conformations in PE and the domain III structures. These are designated L2, residues 517-522, and L3, residues 546-551 ( Figure 6(a) ). Inspection of crystal packing veri®es that these differences cannot be ascribed to differences in intermolecular contacts. Although these loops are not in direct contact with bound substrate or product analogs in the structures of domain III, the conformational variations of these apparently¯exible loops may result from indirect effects of ligand binding. In this context, it is notable that a W466F mutation reduces ADP ribosyl transferase activity 20-fold and glycohydrolase activity threefold. 44 This residue does not interact directly with substrate or product in structures of domain III; however, the side-chain of Trp466 interacts with Ala519 of L2. The W466F mutation may be propagating its effect indirectly by distorting the overall conformation of the substrate binding cleft, rather than by direct interaction with substrate.
Finally, loop L4, residues 486-493, which is very poorly ordered in all structures, shows signi®cant conformational variability, not only between PE and domain III structures, but also between the wild-type and W281A mutant structures. The functional role of this loop has not been de®ned at this time.
During the later stages of re®nement, wellde®ned electron density for a seven-atom molecule appeared in F o À F c maps in the active site cleft of the W281A PE structure (Figure 6(b) ). It approximately overlaps the bound nicotinamide molecule of one of the domain III structures (molecule B of PDB 1DMA), and the density can be``®lled'' with a carboxyl or carboxyamide group plus a fouratom chain, such as valeric acid or valeramide (with a carboxyamide group mimicking that of nicotinamide). The terminal atom on the extended chain of this molecule is $2.3 A Ê from a carboxyl oxygen atom of the catalytic residue Glu553; however, 2F o À F c maps do not show continuous den- sity between these atoms, so the ligand is not covalently linked to Glu553. The appearance of a nonsubstrate small molecule bound to the active site cleft of the enzymatic domain is reminiscent of the binding of ApUp to diphtheria toxin; 45 we note in passing that efforts to bind ApUp to PE and to observe it crystallographically yielded negative results (data not shown). We have been unable to trace this molecule to any component in our crystallization or cryoprotection reagents; hence, although it is well-ordered and presumably tightly bound, both its origin and its identity remain a mystery.
Receptor binding
Studies have identi®ed Lys57 as a residue whose replacement with glutamic acid reduces PE toxicity toward 3T3 cells by two orders of magnitude, apparently by impairing receptor binding. 46 Additionally, insertion of a dipeptide between residues 60 and 61 reduces toxicity af®nity by 500-fold. 47 These data provide circumstantial identi®-cation of the receptor binding region of PE on a concave surface of domain I. The structure of a receptor binding domain of a 2 -macroglobulin has been solved. 48, 49 The fold is an eight-stranded antiparallel b jellyroll topology, reminiscent of the more complex 13-stranded jellyroll of domain Ia from PE. Super®cially, one might suspect that these two domains would share a common receptor binding surface. However, the receptor binding region of the a 2 -macroglobulin receptor binding domain maps primarily to an a-helix that forms a convex surface protruding from the eight-stranded fold. Hence, we cannot identify a structurally equivalent feature in domain I of PE. Therefore, despite their common jellyroll fold, the respective PE and a 2 -macroglobulin receptor binding domains appear to bind the a 2 -macroglobulin receptor in different manners. Pseudomonas Exotoxin A Structure
Summary
The re®ned high-resolution structure of PE reveals details of the molecular structure and intramolecular interactions that were ambiguous in earlier models. Speci®c interactions between domains I and II that may regulate the pH-dependent conformational change of PE have been delineated. The structure displays a well-ordered furin cleavage site, which contrasts with DT and the anthrax protective antigen; the combination of substantial differences in B-factors and minimal differences in static structure of the furin site between wild-type and the W281A mutant structures suggest that exibility, rather than a speci®c tertiary structure, may regulate cleavage susceptibility. The re®ned PE structure also illustrates the molecular constraints that restrain the enzymatic domain in a non-catalytic state in full-length PE. The precision of the current models should facilitate the design and interpretation of further experiments on the molecular mechanisms of PE intoxication.
Materials and Methods

Crystals
Puri®ed wild-type and W281A mutant PE proteins were prepared in the laboratories of R.J.C. and D.F., respectively, and crystallized as described, 32 with substitution of 0.05 to 0.1 M K-Hepps (pH 8.0) for phosphate buffer. Crystals were stabilized in a mother liquor consisting of 20 % (w/v) PEG 8000, 1.0 M NaCl, and 0.05 to 0.1 M K-Hepps (pH 8.0). For cryoprotection, wild-type PE crystals were adapted to mother liquor plus 20 % PEG-400, and W281A crystals were adapted to mother liquor plus 15 % (v/v) ethylene glycol; in both case, the adaptation was carried out stepwise, with 5 % increments of cryoprotectant at 15 minute intervals, at 4 C. Crystals were then captured in thin rayon loops and ash-frozen in a stream of nitrogen gas at $100 K for data collection. Freezing reduced the volume of the unit cell by approximately 4 % from its room temperature value (Table 2) .
X-ray data collection
Data for crystals of wild-type PE were collected both on beamline 7-1 of the Stanford Synchrotron Radiation Laboratory (SSRL) with an MAR Research image plate detector, and in-house on an R-AXIS IIC image plate detector system (Rigaku/MSC) using graphite monochromatized CuK a radiation, since we were unable to complete re-collection of overloaded synchrotron data at the time (Table 1) . In both cases, re¯ection intensities were integrated and scaled, and Lorentz-polarization corrections were applied with DENZO and SCALEPACK. 50 Although no special effort was made for in-house data collection to collect the anomalous diffraction signal, the favorable orientation of the crystal allowed $84.4 % of I and 91.2 % of I À re¯ections to be recorded. Bijvoet mates were treated independently in data reduction. The two datasets were merged in order to compensate for the signi®cant fraction of re¯ections that were discarded as overloaded in the synchrotron data. This was accomplished through local scaling of synchrotron data to in-house data with the program HEAVY v4.5 51 using 27,864 common re¯ections (F/ s(F) > 0) between 10 and 2.25 A Ê resolution. Then, the two datasets were combined using in-house data in the resolution range 50.0-2.40 A Ê and synchrotron data in the range 2.40-1.62 A Ê . The resulting dataset is 95.4 % complete overall.
Data were collected on a crystal of W281A PE on SSRL beamline 9-2 using an ADSC CCD detector. Data were collected in two passes, the ®rst using a 30 second exposure for 0.5 oscillations to optimize signal-to-noise at the higher resolution, and the second using a three second exposure to minimize overloads at lower resolution. Data were processed and scaled with DENZO and SCALEPACK. 50 Statistics are summarized in Table 1 .
Structure determination and refinement
Model building was effected with the program O. 52, 53 Model re®nement was completed with the program package CNS version 1.0. 34 Superposition and comparison of models was done with LSQMAN of the Uppsala Software. 54 The starting model for re®nement of wild-type PE was derived from the atomic coordinates of the 3.0 A Ê structure; 16 8 % of the re¯ections were randomly removed to provide a cross-validation data set. 55 Throughout the re®nement an overall anisotropic B-factor correction was applied to the data; ®nal values for the tensor were: B 11 À 5.49, B 22 2.82, B 33 2.67. Metal-ligand distances and geometry were not restrained in the re®nement. In the ®rst step, temperature factors were set to 24 A Ê 2 based upon a Wilson plot for all data to 2.25 A Ê resolution. Several segments of polypeptide Figure 5 . Difference in average main-chain B-factors between the W281A mutant and wild-type models. Largest positive (W281A more disordered than wildtype) and negative (wild-type more disordered than W281A) differences, at R281 and L4 (residues 486-493) respectively, are highlighted.
were omitted from the initial model, including residues 483-491, 548-551 and 604-613. Rigid body re®nement was performed using data between 15 and 4 A Ê , then extended sequentially to 3.0 A Ê and 2.4 A Ê . The inclusion of low-resolution data was accompanied by use of a bulk solvent correction, calculated after each round of positional re®nement. Rigid body re®nement gave R cryst 0.388 (R free 0.385) for all data between 50 A Ê and 2.4 A Ê resolution. The model was then subjected to positional re®nement, ®rst to 2.7 A Ê resolution, then 2.4 A Ê resolution. Cartesian simulated annealing with a starting temperature of 3000 was applied prior to re-building, reducing the R cryst to 0.269 (R free 0.322) to 2.4 A Ê resolution.
Successive cycles of manual ®tting, followed by positional and restrained individual B-factor re®nement, were carried out with extension of resolution to 2.4, 2.1, 1.8 and 1.62 A Ê . with manual rebuilding of the model into 2F o À F c and F o À F c electron density maps computed with SIGMAA coef®cients at each step. Regions derived from the original unre®ned 3.0 A Ê model that required substantial manual rebuilding include residues Two Na ions and two Cl ions were identi®ed based on their peak height in electron density maps and coordination geometry. Bijvoet differences from the in-house data were used to compute anomalous difference Fouriers to 2.4 A Ê ; peaks in the resulting maps corroborated the assignment of the Cl ions and veri®ed the positions of sulfur atoms in the model. Re®nement and other vital statistics for the ®nal model for wild-type PE are summarized in Table 1 . The W281A mutant structure was solved and re®ned with a similar strategy, using the re®ned wild-type model as a starting point. Initial rigid-body re®nement with the wild-type PE polypeptide to 2.0 A Ê resolution gave R cryst 0.333 (R free 0.334); after torsional simulated annealing and energy minimization, manual rebuilding, and inclusion of solvent molecules, the statistics improved to R cryst 0.227 (R free 0.249). Resolution was then extended to 1.6 A Ê , with re®nement and manual rebuilding, until statistics improved to R cryst 0.220 (R free 0.238), and subsequently to 1.45 A Ê .
Final values for the anisotropic B-factor correction that was applied to the data are: B 11 À 2.60, B 22 0.63, B 33 1.97. Modeling of several poorly ordered loops was veri®ed with simulated annealing omit maps; additionally, the ®nal model was veri®ed with composite omit maps and compared with the wild-type structure for consistency. The ions from the wild-type structure were then included in the model, and residues which showed multiple conformations in F o À F c maps were built with two conformations of equal occupancy. Re®nement and other statistics are summarized in Table 1 .
Computational analysis
The theoretical change in reaction ®eld energy resulting from the protonation of individual residues was computed using the ®nite-difference Poisson-Boltzman method implemented in the program DelPhi. 56 Protons were built onto each selected side-chain using in-house software (P.K., unpublished results) that placed each hydrogen atom with proper distance and angle geometry and rotated the O-H group to avoid steric clashes with the rest of the protein. Two sets of calculations were performed, with the hydrogen atom built onto each of the a R sym AEjI hkl À hI hkl ij/AEhI hkl i, where I hkl single value of measured intensity of hkl re¯ection, and hIi mean of all measured value intensity of hkl re¯ection.
b R cryst AEjF obs À F calc j/AEF obs , where F obs observed structure factor amplitude and F calc structure factor calculated from model. R free is computed in the same manner as R cryst , using the test set of re¯ections.
two carboxylic acid oxygen atoms. CHARMM22 charges and atomic radii were used for the DelPhi calculations. 57 The charges of the remaining residues and the amino and carboxy termini were maintained at their standard values at pH 7.0. The two Na and two Cl ions were included in the calculations, as was a single water molecule that mediates the salt bridge interaction between Asp139 and Arg274.
Protein Data Bank accession numbers
The coordinates of wild-type and W281A mutant PE have been deposited in the RCSB Protein Data Bank, accession numbers 1IKQ and 1IKP, respectively.
Note added in proof
DNA sequencing has recently identi®ed a P201Q mutation in the coding sequence of the PA toxin gene in the expression plasmid for recombinant W281A mutant toxin (D.F., personal communication). We have con®rmed the presence of the P201Q mutation in the W281 mutant protein used in this study by inspection of electron density maps. Residue 201 is $35 A Ê from the furin cleavage site; conclusions regarding the W281A mutation are unlikely to be in¯uenced by the P201Q mutation.
